A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data Supplement - Manuscript file of format pdf
About the toc
doi: 10.1136/bmjopen-2011-000223 BMJ Open 1 January 2011 vol. 1 no. 2
- Supplementary Data